Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
The purpose of this study is to evaluate the efficacy, safety, and tolerability of
levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major
Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics
(PK) data to guide dose selection for future pediatric studies of levomilnacipran.
Levomilnacipran ER vs. Adjunctive Quetiapine ER for Adults With Inadequate Relief With SSRIs in MDD
Not yet recruiting
This study's primary objective is to compare the efficacy and tolerability of switching
patients with inadequate relief on generic SSRIs to levomilnacipran versus adding a new
treatment (quetiapine ER) to your existing treatment with people diagnosed with depression
(major depression disorder).
The secondary objective is to examine the response and remission rates following the switch
from a generic SSRI to levomilnacipran ER and augmentation with quetiapine along with
examining changes in neurocognitive and apathy measures after the switch.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.